Humana Inc (HUM) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.052x

Based on the latest financial reports, Humana Inc (HUM) has a cash flow conversion efficiency ratio of 0.052x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($971.00 Million) by net assets ($18.58 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Humana Inc - Cash Flow Conversion Efficiency Trend (1990–2024)

This chart illustrates how Humana Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read HUM total debt and obligations for a breakdown of total debt and financial obligations.

Humana Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Humana Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Public Bank Bhd
KLSE:1295
0.028x
Airports Of Thailand PCL
BK:AOT
0.071x
Loews Corp
NYSE:L
0.031x
AerCap Holdings NV
NYSE:AER
0.065x
Kuehne + Nagel International AG
F:KNIU
0.175x
Vinhomes JSC
VN:VHM
-0.009x
XPO Logistics Inc
NYSE:XPO
0.121x
Hengli Petrochemical Co Ltd
SHG:600346
0.010x

Annual Cash Flow Conversion Efficiency for Humana Inc (1990–2024)

The table below shows the annual cash flow conversion efficiency of Humana Inc from 1990 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Humana Inc worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $16.45 Billion $2.97 Billion 0.180x -26.07%
2023-12-31 $16.32 Billion $3.98 Billion 0.244x -18.25%
2022-12-31 $15.37 Billion $4.59 Billion 0.298x +112.46%
2021-12-31 $16.10 Billion $2.26 Billion 0.140x -65.80%
2020-12-31 $13.73 Billion $5.64 Billion 0.411x -6.43%
2019-12-31 $12.04 Billion $5.28 Billion 0.439x +105.27%
2018-12-31 $10.16 Billion $2.17 Billion 0.214x -48.04%
2017-12-31 $9.84 Billion $4.05 Billion 0.412x +127.17%
2016-12-31 $10.69 Billion $1.94 Billion 0.181x +115.97%
2015-12-31 $10.35 Billion $868.00 Million 0.084x -49.98%
2014-12-31 $9.65 Billion $1.62 Billion 0.168x -8.94%
2013-12-31 $9.32 Billion $1.72 Billion 0.184x +66.36%
2012-12-31 $17.37 Billion $1.92 Billion 0.111x -57.06%
2011-12-31 $8.06 Billion $2.08 Billion 0.258x -20.36%
2010-12-31 $6.92 Billion $2.24 Billion 0.324x +31.55%
2009-12-31 $5.78 Billion $1.42 Billion 0.246x +11.68%
2008-12-31 $4.46 Billion $982.31 Million 0.220x -27.47%
2007-12-31 $4.03 Billion $1.22 Billion 0.304x -44.98%
2006-12-31 $3.05 Billion $1.69 Billion 0.552x +118.42%
2005-12-31 $2.47 Billion $625.63 Million 0.253x +51.96%
2004-12-31 $2.09 Billion $347.81 Million 0.166x -26.05%
2003-12-31 $1.84 Billion $413.14 Million 0.225x +12.47%
2002-12-31 $1.61 Billion $321.41 Million 0.200x +102.54%
2001-12-31 $1.51 Billion $148.96 Million 0.099x +235.86%
2000-12-31 $1.36 Billion $40.00 Million 0.029x -83.51%
1999-12-31 $1.22 Billion $217.00 Million 0.178x +296.22%
1998-12-31 $1.69 Billion $76.00 Million 0.045x -79.45%
1997-12-31 $1.32 Billion $289.00 Million 0.219x -16.98%
1996-12-31 $1.29 Billion $341.00 Million 0.264x +126.45%
1995-12-31 $1.29 Billion $150.00 Million 0.117x -58.62%
1994-12-31 $1.06 Billion $298.00 Million 0.282x +35.35%
1993-12-31 $889.00 Million $185.00 Million 0.208x -37.76%
1992-12-31 $2.02 Billion $674.00 Million 0.334x +11.20%
1991-12-31 $2.01 Billion $604.00 Million 0.301x -30.63%
1990-12-31 $1.75 Billion $758.30 Million 0.433x --

About Humana Inc

NYSE:HUM USA Healthcare Plans
Market Cap
$28.10 Billion
Market Cap Rank
#1117 Global
#459 in USA
Share Price
$233.63
Change (1 day)
-1.19%
52-Week Range
$163.67 - $312.00
All Time High
$553.59
About

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. It offers medical care and supplemental benefit plans to individuals. The company also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with … Read more